Results 181 to 189 of about 110,931 (189)

Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study

Annals of Oncology, 2018
Silvia Hofer, Sabine Rohrmann, Nicolaus Andratschke   +2 more
exaly  

Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers

Journal of Thoracic Oncology, 2013
Naiyer A Rizvi, Jamie Chaft, Valerie Rusch   +2 more
exaly  

Bevacizumab toxicities and their management in ovarian cancer

Gynecologic Oncology, 2010
Leslie Randall
exaly  

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Gynecologic Oncology, 2018
Don S Dizon, Virginia Filiaci, David Omalley   +2 more
exaly  

Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis

European Journal of Cancer, 2019
Alexander Baraniskin, Volker Heinemann, Wolff Schmiegel   +2 more
exaly  

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Annals of Oncology, 2018
Bhawna Sirohi, Paul Lorigan, Mark Middleton   +2 more
exaly  

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Annals of Oncology, 2014
Christos Chouaid, M J Ahn, A Rittmeyer   +2 more
exaly  

Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review

Cancer Treatment Reviews
Bradley Monk, Jalid Sehouli, Keiichi Fujiwara   +2 more
exaly  

Bevacizumab

Reactions Weekly, 2016
openaire   +1 more source